Filter Results:
(396)
Show Results For
- All HBS Web
(396)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
Show Results For
- All HBS Web
(396)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (248)
- April 1981 (Revised March 1993)
- Case
General Electric: Strategic Position--1981
By: Francis Aguilar and Richard G. Hamermesh
Describes the introduction and evolution of General Electric's strategic planning system from the 1960s to Jack Welch's tenure. Allows discussion of the interplay of problems and circumstances to the evolution of the strategic planning system, and how Welch might use... View Details
Aguilar, Francis, and Richard G. Hamermesh. "General Electric: Strategic Position--1981." Harvard Business School Case 381-174, April 1981. (Revised March 1993.)
- November 2012
- Supplement
Sugar Bowl, Spreadsheet for Instructors (Brief Case) (CW)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Student Spreadsheet (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (E): Judge Stein Rules
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (E): Judge Stein Rules." Harvard Business School Supplement 806-081, January 2006. (Revised May 2007.)
- December 2003 (Revised September 2004)
- Case
Managing Segway's Early Development
By: Richard G. Hamermesh and David Kiron
Describes the early development of the Segway Human Transporter and focuses on the organizational issues that arise between the parent company and the new company that is being spun out to produce and market the Segway. Key issues are the distribution of bonuses and... View Details
Keywords: Business Subsidiaries; Business Startups; Employee Stock Ownership Plan; Resource Allocation; Organizational Design; Technology Adoption
Hamermesh, Richard G., and David Kiron. "Managing Segway's Early Development." Harvard Business School Case 804-065, December 2003. (Revised September 2004.)
- January 2002 (Revised July 2002)
- Case
Vialog Corporation
By: Richard G. Hamermesh and Michele Lutz
Traces the origin of Vialog Corp.--from its founding in 1996 through a roll-up of several independent teleconferencing companies in 1997 and its initial public offering (1999) and eventually to a potential merger or acquisition in June 2000. The company has grown... View Details
Keywords: History; Business Exit or Shutdown; Internet and the Web; Corporate Entrepreneurship; Partners and Partnerships; Initial Public Offering; Business Growth and Maturation; Mergers and Acquisitions; Business Processes; Information Technology Industry; Europe
Hamermesh, Richard G., and Michele Lutz. "Vialog Corporation." Harvard Business School Case 802-008, January 2002. (Revised July 2002.)
- January 2001 (Revised April 2001)
- Teaching Note
Lawyers & Leases TN
By: Richard G. Hamermesh and Michele Lutz
Teaching Note for (9-801-166). View Details
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- May 2012
- Supplement
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Instructors (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2012
- Supplement
Sugar Bowl, Spreadsheet for Students (Brief Case) (CW)
By: Richard G. Hamermesh and Alisa Zalosh
- December 2012
- Teaching Note
Gene Patents (A) (TN)
By: Richard G. Hamermesh and Matthew Preble
This is the teaching note for case Gene Patents (A). In March 2010, U.S. District Court Judge Robert Sweet overturned 30 years of legal precedent and ruled that unaltered human genes could not be patented. This case reviews patent law and how it relates to our... View Details
- July 2012 (Revised May 2024)
- Supplement
Lyric Dinner Theater (B)
By: Richard G. Hamermesh and Jim Sharpe
Supplements the (A) Case. Deborah Denenberg reflects on the results and actions taken during the 12 months following her first 6 months on the job. View Details
Keywords: Entrepreneurs; Entrepreneurial Management; Crisis; Turn; Family Business; Financial Crisis; Boards Of Directors; Operations Management; Strategy Implementation; Career Planning; Entrepreneurship; Entertainment and Recreation Industry; United States
Hamermesh, Richard G., and Jim Sharpe. "Lyric Dinner Theater (B)." Harvard Business School Supplement 813-044, July 2012. (Revised May 2024.)
- October 2010 (Revised June 2015)
- Teaching Note
MINTing Innovation at NewYork-Presbyterian (A) and (B)
By: Richard G. Hamermesh and David Kiron
Teaching Note for 810004 and 815113. View Details
- April 2009
- Teaching Note
Amylin Pharmaceuticals: Diabetes and Beyond (TN)
By: Richard G. Hamermesh and Rachel Gordon
Teaching Note for [809011]. View Details
- September 2007 (Revised October 2010)
- Case
DermaCare: Zapping Zits Directly
By: Richard G. Hamermesh and Lauren Barley
DermaCare has developed an innovative new product for the treatment of acne that they hope to sell to consumers via direct-response television. The unconventional nature of the product and its distribution has led the company to seek angel financing. The Silicon Valley... View Details
Keywords: Decision Choices and Conditions; Venture Capital; Investment; Innovation and Invention; Product; California
Hamermesh, Richard G., and Lauren Barley. "DermaCare: Zapping Zits Directly." Harvard Business School Case 808-064, September 2007. (Revised October 2010.)
- October 2006 (Revised August 2007)
- Case
Calloway Laboratory: Pee for Profit
By: Richard G. Hamermesh and David Kiron
Describes the formation and rapid growth of a drug-testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. View Details
Keywords: For-Profit Firms; Health Care and Treatment; Health Testing and Trials; Growth and Development Strategy; Market Entry and Exit; Health Industry
Hamermesh, Richard G., and David Kiron. "Calloway Laboratory: Pee for Profit." Harvard Business School Case 807-040, October 2006. (Revised August 2007.)
- May 2006
- Teaching Note
WuXi PharmaTech (TN)
By: Richard G. Hamermesh and Erin Seefeld
Keywords: Pharmaceutical Industry
- March 2006 (Revised February 2009)
- Teaching Note
Molecular Insight Pharmaceuticals, Inc. (TN)
By: Richard G. Hamermesh and Erin Seefeld
Teaching Note to (805-067). View Details
Keywords: Pharmaceutical Industry